Milestone
Portfolio company NOWDiagnostics received FDA De Novo marketing authorization for its First To Know OTC syphilis test.
NOWDiagnostics
AUG 2024
Every public signal F4 has attached to this firm, with sources and cross-entity links.
NOWDiagnostics
NOWDiagnostics
DivvyHQ